[1] |
GAO Jingya, HU Hongxiang, XIAO Yue, XIA Dengmei, JIANG Lu, LI Wei.
Clinical analysis of 8 cases with plaque psoriasis complicated by HIV infected treated with biologics
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 559-563.
|
[2] |
ZHOU Meng, SUO Panpan, LIU Baoguo, LYU Chao, WANG Xin, MIAO Guoying.
Efficacy of biological agents or small molecular targeted drugs in the treatment of 6 cases with refractory pityriasis rubra pilaris
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 583-586.
|
[3] |
QI Chunyan, SHE Xinyan, CAI Liting, GUAN Zepu, WANG Xiaohua, QIU Xiaoyu.
Characteristics and severity correlation analysis of nail damage in moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 400-405.
|
[4] |
WU Qiaofang, BAO Jun, SUN Yuexin, TAO Yue.
Efficacy and safety of tildrakizumab in the treatment of 32 patients with moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 410-415.
|
[5] |
YU Wanlong, BAI Fan, YANG Yinan, LI Shuangshuang, XU Yabo, CHANG Feiyu, LEI Mingjun.
Generalised pustular psoriasis with alopecia treated with deucravacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 450-452.
|
[6] |
HU Hongxiang, GAO Jingya, ZHOU Xingli, LI Wei.
Guselkumab for the treatment of psoriasis combined with AIDS and hepatitis C: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 276-278.
|
[7] |
LIN Zhaoping, CHEN Chaofeng, GAO Jing, HUANG Cong, YU Bo, SHEN Changbing.
Chronic disease management of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(3): 226-230.
|
[8] |
SONG Pingping, WANG Na, DU Donghong, LIU Jing, RAN Delin, YANG Baoqi.
Generalized pustular psoriasis successfully treated with spesolimab: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 127-129.
|
[9] |
ZHANG Meng, SUN Yuexin, LI Zhiyu, BAO Jun, ZHOU Ying.
Acute generalized pustular psoriasis treated with spesolimab: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 37-42.
|
[10] |
YAO Xinyi, HE Tong, YANG Xinya, XU Mingcheng, ZHANG Junling.
Research progress on interleukin-17C in autoimmune skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 69-72.
|
[11] |
XUE Huaiyu, JI Huilin, ZHU Yidi, LIU Qingna, WEI Zhiping.
Correlation between adipokine, BMI and metabolic syndrome in the patients with psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(9): 612-617.
|
[12] |
WANG Wansi, SHEN Jiaqing, LIU Yi.
Update of TIGIT and related skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 377-382.
|
[13] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|
[14] |
HAN Junya, WU Weiwei, HE Xiaojun, ZHU Wenwen, FANG Xianfeng.
Related factors analysis and prediction model establishment of malignant tumor in patients with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 157-162.
|
[15] |
CHANG Jiayu, QI Miao, WANG Yimin, LI Yongxi, SHI Tongxin.
Bullous pemphigoid occurred in a patient with severe plaque psoriasis treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 199-201.
|